Is CGON research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CGON. It does not provide personalized investment advice.

CGON (CG Oncology, Inc. Common stock) Stock Analysis - Financials

CG Oncology, Inc. Common stock (CGON) is a publicly traded Healthcare sector company. As of September 7, 2026, CGON trades at $74.67 with a market cap of $6.62B and a P/E ratio of -27.76. CGON moved +0.47% today. Year to date, CGON is +79.84%; over the trailing twelve months it is +125.79%. Its 52-week range spans $14.80 to $80.97. Analyst consensus is strong buy with an average price target of $91.80. Rallies surfaces CGON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CGON's key financials?

CGON financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CGON recently traded at $74.67. Market cap is $6.62B. P/E ratio is -27.76. Revenue is $6.23M.

CGON Key Metrics

Key financial metrics for CGON
Metric	Value
Price	$74.67
Market Cap	$6.62B
P/E Ratio	-27.76
EPS	$-2.69
Dividend Yield	0.00%
52-Week High	$80.97
52-Week Low	$14.80
Volume	0
Avg Volume	0
Revenue (TTM)	$6.23M
Net Income	$-224.38M
Gross Margin	0.00%

CGON Analyst Consensus

10 analysts cover CGON: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $91.80.

Common questions about CGON

What are CGON's key financials?: CGON financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CGON recently traded at $74.67. Market cap is $6.62B. P/E ratio is -27.76. Revenue is $6.23M.
Is CGON research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CGON. It does not provide personalized investment advice.